« Back
Modeling Sundowning Syndrome in Mouse Models of Alzheimer
Poster Title: Modeling Sundowning Syndrome in Mouse Models of Alzheimer's Disease
Submitted on 22 Feb 2018
Affiliations: Mol. Med., USF Health Morsani College of Medicine, Tampa, FL
This poster was presented at USF Research Day
Poster Views: 520
View poster »

Poster Information
Abstract: Sundowning Syndrome (SS) is a significant constellation of circadian expressed symptoms found in Alzheimer’s disease (AD) that devastates patients as well as placing increased burden caregivers. Current treatment options are scant. Here, we use two distinct mouse models of SS to study whether an inhibitor of casein kinase 1 epsilon delta (CK1ε/δ) can improve circadian rhythmicity and behavior. CK1ε/δ are key regulators of the biological clock. Our models of SS are aged C57BL/6J mice which is a model of aging, and a model of amyloid precursor protein pathology: the APP/PS1 mice, both of which show symptoms characteristic of SS. Using measurement of wheel running and drinking behavior we can assess the recovery of circadian activity patterns. Using a series of behavioral tests at multiple time points we can measure the change in cognitive performance. The CK1ε/δ inhibitor has shown success in recovering circadian rhythm in the mouse models that show dysfunctional patterns of circadian rhythmicity. Continuing behavior experiments are characterizing the changes in cognitive function of mouse models of SS in a circadian fashion that administration of the drug engenders. The results show that directly manipulating effectors of the biological clock provides a novel means of treating SS and improving the lives of AD patients as well as their caregivers.Summary: We have found ways in which modulating the circadian clock can have impacts in neurodegenerative disease, raising potential for therapeutic use in circadian expressed symptom control. Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Distinct deposition of amyloid-bspecies in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry
Nobuto Kakuda1, Tomohiro Miyasaka1, Takashi Nirasawa2, Shigeo Murayama3, Yasuo Ihara1 and Masaya Ikegawa1

Traumatic Eyeball Luxation: A stepwise approach to Globe Salvage
Varun Sarodaya, Himika Gupta, Shrikant Deshpande, Srivalli Nataranjan

The new cavity classification LOV/DD
Oleksandr Bulbuk, Olena Bulbuk, Mykola Rozhko

A Novel Enzymatic Assay for Determination of Phosphatidylinositol in Biological Samples
Paul Templeton, Kyle C. Schmitt, Grigoriy Tchaga,and Gordon Yan

Improved Expansion of Neural Stem Cells with Gibco™ Heat Stable Recombinant Human Basic Fibroblast Growth Factor
Brittany Balhouse, Diana Navarro, Richard Josephson, and Matthew Dallas